Letter: faecal microbiota transplantation for irritable bowel syndrome-which improvements are required? Authors' reply

被引：0
|
作者：
Perttu, Lahtinen [1 ,2 ]
Jonna, Jalanka [3 ]
Anna, Hartikainen [3 ]
Eero, Mattila [4 ]
Markku, Hillila [2 ,5 ]
Jari, Punkkinen [6 ]
Jari, Koskenpato [7 ]
Veli-Jukka, Anttila [2 ,4 ]
Jyrki, Tillonen [1 ]
Reetta, Satokari [3 ]
Perttu, Arkkila [2 ,8 ]
机构：
[1] Paijat Hame Cent Hosp, Dept Gastroenterol, Lahti, Finland
[2] Univ Helsinki, Fac Med, Helsinki, Finland
[3] Univ Helsinki, Fac Med, Human Microbiome Res Program, Helsinki, Finland
[4] Helsinki Univ Hosp, Dept Infect Dis, Helsinki, Finland
[5] Helsinki Univ Hosp, Dept Gastroenterol, Espoo, Finland
[6] Porvoo Hosp, Dept Gastroenterol, Porvoo, Finland
[7] Aava Med Ctr, Dept Gastroenterol, Helsinki, Finland
[8] Helsinki Univ Hosp, Dept Gastroenterol, Helsinki, Finland
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2020年 / 52卷 / 11-12期
关键词：
SYNDROME-ROOM;
D O I：
10.1111/apt.16122
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1754 / 1755
页数：2
相关论文
共 50 条
  • [1] Letter: faecal microbiota transplantation for irritable bowel syndrome-which improvements are required?
    El-Salhy, Magdy
    Hausken, Trygve
    Gunnar Hatlebakk, Jan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (11-12) : 1752 - 1753
  • [2] Letter: faecal microbiota transplantation for irritable bowel syndrome. Authors' reply
    Lahtinen, Perttu
    Jalanka, Jonna
    Hartikainen, Anna
    Mattila, Eero
    Hillila, Markku
    Punkkinen, Jari
    Koskenpato, Jari
    Anttila, Veli-Jukka
    Tillonen, Jyrki
    Satokari, Reetta
    Arkkila, Perttu
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (03) : 557 - 558
  • [3] Letter: faecal microbiota transplantation for irritable bowel syndrome-room for improvement. Authors' reply
    Lahtinen, Perttu
    Jalanka, Jonna
    Hartikainen, Anna
    Mattila, Eero
    Hillila, Markku
    Punkkinen, Jari
    Koskenpato, Jari
    Anttila, Veli-Jukka
    Tillonen, Jyrki
    Satokari, Reetta
    Arkkila, Perttu
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (05) : 925 - 926
  • [4] Letter: faecal microbiota transplantation for irritable bowel syndrome-room for improvement
    Ianiro, Gianluca
    Porcari, Serena
    Ford, Alexander Charles
    Gasbarrini, Antonio
    Cammarota, Giovanni
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (05) : 923 - 924
  • [5] Letter: determining priorities for patients with faecal incontinence and irritable bowel syndrome--authors' reply
    Goodoory, Vivek C.
    Ng, Cho E.
    Black, Christopher J.
    Ford, Alexander C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (01) : 139 - 140
  • [6] Letter: Irritable bowel syndrome and antibiotics-Authors' reply
    Staller, Kyle
    Ludvigsson, Jonas F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (03) : 422 - 422
  • [7] Randomised clinical trial: Faecal microbiota transplantation for irritable bowel syndrome with diarrhoea
    Yau, Yuk Kam
    Su, Qi
    Xu, Zhilu
    Tang, Whitney
    Ching, Jessica Y. L.
    Mak, Joyce Wing Yan
    Cheung, Chun Pan
    Fung, Matthew
    Ip, Margaret
    Chan, Paul Kay Sheung
    Wu, Justin Che Yuen
    Chan, Francis Ka Leung
    Ng, Siew C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (08) : 795 - 804
  • [8] No benefit of faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2019, 80 (09) : 498 - 498
  • [9] Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome
    El-Salhy, Magdy
    Casen, Christina
    Valeur, Jorgen
    Hausken, Trygve
    Hatlebakk, Jan Gunnar
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (18) : 2219 - 2237
  • [10] Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome
    Magdy El-Salhy
    Christina Casen
    J?rgen Valeur
    Trygve Hausken
    Jan Gunnar Hatlebakk
    World Journal of Gastroenterology, 2021, 27 (18) : 2219 - 2237
12345